Recent Posts


Lung Cancer Research: How You Can Make a Difference

January 23rd, 2020|Hot Topics, News|

Did you know that you can help change the future of lung cancer? One of GO2 Foundation’s core pillars is to advance world-class, patient-centered, academic and community-based research that spans the continuum of care. To achieve this we, along with our partners and collaborators, offer our community many opportunities [...]

Advances in Lung Cancer Treatment Drops U.S. Cancer Deaths

January 9th, 2020|Hot Topics, News|

GO2 Foundation for Lung Cancer points to targeted treatments and early screenings SAN CARLOS, Calif. and WASHINGTON, Jan. 8, 2020 /PRNewswire/ -- Today's report concerning improvements in cancer mortality is welcomed news. The recently released Cancer Statistics 2020 report shows that the decline in lung cancer deaths is driving the decrease in mortality rates for cancer [...]

Year-end Progress for the Lung Cancer Community: Federal Research Funding & the Women and Lung Cancer Research and Preventive Services Act

December 21st, 2019|Hot Topics, News|

For many weeks, our community has been awaiting passage of the Fiscal Year 2020 (FY20) federal budget, which funds the Lung Cancer Research Program. This week, just days before the budget continuing resolution expired, the House and Senate released the long-awaited conferenced agreement that has been signed by the [...]

Stories That Inspire

December 19th, 2019|Hot Topics, Stories of Hope|

From advancements in research and progress on Capitol Hill, to working directly with survivors and families, 2019 has been a monumental inaugural year for us at GO2 Foundation. At the heart of everything we do is our patient community; you continue to inspire and motivate us every day. Some [...]

Lung Cancer Registry Launches New Surveys

December 13th, 2019|Hot Topics, News|

SAN CARLOS, Calif. and WASHINGTON DC, December 12, 2019 – The Lung Cancer Registry has launched new surveys to do an even better job of capturing important moments in a patient’s lung cancer journey. These new surveys include questions about how symptoms and side effect impact quality of life—now and [...]

FDA Approves Tecentriq Plus Chemotherapy as a First-Line Treatment for Metastatic NSCLC

December 5th, 2019|Hot Topics, News|

On December 3, 2019, the U.S. Food and Drug Administration approved Tecentriq (atezolizumab) in combination with chemotherapy (Abraxane [paclitaxel protein-bound; nab-paclitaxel] and carboplatin) as a first treatment for patients with metastatic non-squamous non-small cell lung cancer (NSCLC) with no EGFR or ALK changes. This approval is based on the [...]

GO2 Foundation for Lung Cancer Announces Young Innovators Team Award Recipients

December 3rd, 2019|Hot Topics, News|

SAN CARLOS, Calif., Dec. 3, 2019 -- GO2 Foundation for Lung Cancer announced the recipients of the 2019 Young Innovators Team Awards (YITA) today. Two teams of researchers received grants totaling $500,000 for their work developing novel strategies to treat KRAS-mutant non-small cell lung cancer (NSCLC) and examining the impact of age on development, progression, and [...]

The Power of Partnerships—EGFR-Mutant Lung Cancer

November 21st, 2019|Hot Topics|

We fight lung cancer together. That’s a lesson we’ve learned and put into action. Amy C. Moore, PhD, our Director of Science & Research, recently published an article in the International Association for the Study of Lung Cancer online news about the importance of building research models utilizing partnerships [...]

It’s Time to Shine!

October 31st, 2019|Events, Hot Topics|

Can you believe Lung Cancer Awareness Month kicks off tomorrow? Our Shine a Light on Lung Cancer events make it easy for you to celebrate and remember survivors, caregivers and all individuals who have been impacted by the disease. What can you expect at a Shine a Light event? [...]

A Reason to Run: Chris’s Story

October 17th, 2019|Hot Topics|

Chris Palumbo, born and raised in Rochester, New York, is often found running races and participating in endurance challenges in his home city and beyond. He carries the GO2 Foundation flag with him in support of his best friend Jeff Clark, who was diagnosed with stage IV NSCLC ALK+ [...]

Are You Biomarker Savvy?

October 3rd, 2019|Hot Topics|

Every person’s cancer is different. Between all of the lung cancer treatment options available, how can you and your treatment team identify the best path for your individual case? Enter: biomarker testing. Biomarker testing (also called molecular testing) looks for biological changes, like EGFR or ALK, that may be [...]

A Caregiver’s View

September 26th, 2019|Hot Topics, Stories of Hope|

By Danielle Hicks, Chief Patient Officer, GO2 Foundation for Lung Cancer I became a caregiver when my mom was diagnosed with stage 3B lung cancer in 2003. It was one of most terrifying things I had ever had to face up until that point in my life.  She was [...]

Know Your Nodules

September 5th, 2019|Hot Topics|

Decoding lung cancer terminology can be tough—but we’re here to make it easier. In this blog, we’ll help you better understand nodules, also known as lesions, coin lesions, growths, or solitary pulmonary nodules. Nodules are abnormal (yet common) spots that may show up on your lung cancer screening scan [...]

Quality of Life

August 29th, 2019|Hot Topics|

Isn’t that what it’s all about? Whether a CT scan detects lung cancer early or treatment navigation helps you receive biomarker testing or a HelpLine staff member virtually holds a hand, enhancing quality of life for you and all the lung cancer community is of paramount importance. Support can be [...]

Pedaling for Lung Cancer Awareness

August 22nd, 2019|Hot Topics|

How far will someone go to raise awareness about lung cancer? Try 1,800 miles. That’s how far the participants in the Ride Hard Breathe Easy Classic (RHBE) will pedal to recognize the need for enhanced visibility and funding, and to offer hope for future treatments for lung cancer. Started [...]